Australia's Therapeutic Goods Administration (TGA), responsible for approval of the safety, quality, and efficacy of therapeutic goods, has determined that Skyhawk's SKY-0515 orally-administered small ...

AMT-130 Huntington’s gene therapy data, FDA Phase III sham-trial push, cash runway, and 2026 catalysts—read now.

Days after FDA Commissioner Marty Makary appeared to malign uniQure’s AMT-130 in an interview with CNBC, the agency confirmed ...

Shares of uniQure plummeted more than 40% in premarket trading Monday after the company confirmed the FDA has rejected its current data package for AMT-130, a highly anticipated gene therapy for ...

Vico Therapeutics has started patient dosing in an expanded cohort under a twice-yearly regimen for its Phase I/IIa clinical ...

NASA’s Chandra X-ray Observatory captured a protective astrosphere around HD 61005, providing direct observation of a Sun-like star’s wind interacting with surrounding interstellar material ...

A practical roundup of budget laptops that focus on real-world performance. These picks handle daily work, study, streaming ...

Australia's Therapeutic Goods Administration (TGA), responsible for approval of the safety, quality, and efficacy of therapeutic goods, has determined that Skyhawk's SKY-0515 orally-administered ...

Webb Telescope finds crystalline water ice around star HD 181327. This discovery could reveal how icy bodies contribute to ...

Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against uniQure N.V. (NASDAQ: QURE) (“uniQure” or the “Company”) on behalf of ...

Held Type A meeting with FDA to discuss AMT-130 for Huntington's disease; Company evaluating Phase III development considerations and plans to request follow-up Type B meeting in the second quarter of ...

Speed and efficiency define modern laptops, with Dell, HP, Lenovo, and ASUS leading the charge. These top 5 laptops under 60000 with SSD deliver instant responsiveness, smooth multitasking, and fast ...